Cite Filings / QURE
Feed Companies Filings Check
Sign in

CIK 0001590560

  • Large accelerated filer

uniQure N.V.

Sign in to watch
Ticker
QURE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
Phone
+1 339-970-7000
Business address
PAASHEUVELWEG 25A, AMSTERDAM, Netherlands, 1105 BP
Former names
uniQure B.V.
Filings Financials Insiders Search text
All 955 Financials 198 Shareholder Meetings 25 Executive Compensation 182 Insider Trading 433 Beneficial Ownership Interest 126 Business Combinations 156 Public Offerings 36 Foreign Private Issuers 56 Mutual Funds and ETFs 15 Others 96
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-04-27
  3. DEF 14A Proxy Proxy Statement 2025-04-28
  4. DEF 14A Proxy Proxy Statement 2024-04-24
  5. DEF 14A Proxy Proxy Statement 2023-10-06
  6. DEF 14A Proxy Proxy Statement 2023-04-28
  7. DEF 14A Proxy Proxy Statement 2022-04-29
  8. DEF 14A Proxy Proxy Statement 2021-09-17
  9. DEF 14A Proxy Proxy Statement 2021-04-30
  10. DEF 14A Proxy Proxy Statement 2020-11-02
  11. DEF 14A Proxy Proxy Statement 2020-04-29
  12. DEF 14A Proxy Proxy Statement 2019-05-10
  13. DEF 14A Proxy Proxy Statement 2018-09-26
  14. DEF 14A Proxy Proxy Statement 2018-04-30
  15. DEF 14A Proxy Proxy Statement 2017-08-15
  16. DEF 14A Proxy Proxy Statement 2017-05-01

Page 1 of 1 · 15 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…